Glaxo to stop paying doctors to promote its drugs
December 18 , 2013
British company GlaxoSmithKline is the first major drug company to take such a step: Reports suggest that the company is going to complete a plan by 2016 and stop paying doctors to hawk its drugs.
According to the AP, the move is a "major shift" for the company and comes as China investigates it for illegally paying doctors and officials in order to boost the sales of its products. However, the CEO denied that and said the decision didn't have anything to do with the investigation.
The move is instead "designed to bring greater clarity and confidence that whenever we talk to a doctor, nurse, or other prescriber, it is patients' interests that always come first," he said.
A critic mentioned that this is an important step in the right direction but the company will keep handing out "unsolicited, independent education grants" in order to inform doctors about its drugs.